홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 2-[3-Iodo-4-(1,3-oxazol-5-yl)phenyl]-1,3-benzothiazol-6-ol

HRID 910238
인쇄

반응식

HRID 910238 반응식
NC1SC2C=C(OC)C=CC=2N=1.[OH-].[K+].BrC1C=C(C2SC3C=C(OC)C=CC=3N=2)C=CC=1C1OC=NC=1.[I:38][C:39]1[CH:44]=[C:43]([C:45]2[S:46][C:47]3[CH:53]=[C:52]([O:54]C)[CH:51]=[CH:50][C:48]=3[N:49]=2)[CH:42]=[CH:41][C:40]=1[C:56]1[O:60][CH:59]=[N:58][CH:57]=1.B(Br)(Br)Br.Cl>O.ClCCl.C(O)(=O)C>[I:38][C:39]1[CH:44]=[C:43]([C:45]2[S:46][C:47]3[CH:53]=[C:52]([OH:54])[CH:51]=[CH:50][C:48]=3[N:49]=2)[CH:42]=[CH:41][C:40]=1[C:56]1[O:60][CH:59]=[N:58][CH:57]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 6

HCID 313Hydrochloric AcidHCID 14797Potassium HydroxideHCID 156302-Amino-6-methoxybenzothiazoleHCID 25134Boron tribromideHCID 674042425-[2-Iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole2회HCID 674057305-[2-Bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole2회

생성물

1
HCID 674039232-[3-Iodo-4-(1,3-oxazol-5-yl)phenyl]-1,3-benzothiazol-6-ol

시약·촉매·용매 3

HCID 176Acetic Acid용매HCID 962Water용매HCID 6344Dichloromethane용매

실험 절차

2-Amino-6-methoxybenzothiazole (3.0 g) was added to a solution (100 mL) of potassium hydroxide (21.9 g) in water, followed by refluxing under heating for 15 hours. The mixture was neutralized with 5N aqueous acetic acid solution, and the precipitated crystals were recovered through filtration. The procedure of Referential Example 22 was repeated, except that the thus-recovered 2-amino-5-methoxy-1-benzenethiol (185 mg) and 3-bromo-4-(1,3-oxazol-5-yl)benzaldehyde (300 mg), which had been produced in Referential Example 26, were used, to thereby yield 5-[2-bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (450 mg). Subsequently, The procedure of Referential Example 12 was repeated, except that 5-[2-bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (450 mg) was used, to thereby yield 5-[4-(6-methoxy-1,3-benzothiazol-2-yl)-2-(1,1,1-tributylstannyl)phenyl]-1,3-oxazole (15 mg). Thereafter, the procedure of Example 12 was repeated, except that 5-[4-(6-methoxy-1,3-benzothiazol-2-yl)-2-(1,1,1-tributylstannyl)phenyl]-1,3-oxazole (15 mg) was used, to thereby yield 5-[2-iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole. Under a stream of argon, boron tribromide (200 μL, 1M dichloromethane solution) was added dropwise to a solution (30 mL) of 5-[2-iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (20 mg) in dichloromethane, and the mixture was stirred at room temperature for 23 hours. 1N Aqueous hydrochloric acid solution was added to the reaction mixture, followed by extraction with ethyl acetate. The solvent was evaporated, and the residue was purified through silica gel column chromatography (n-hexane:ethyl acetate=1:1), to thereby yield the title compound (10 mg).

후처리

  1. temperatureby refluxing
  2. temperatureunder heating for 15 hours
  3. filtrationthe precipitated crystals were recovered through filtration
  4. customhad been produced in Referential Example 26
  5. extractionfollowed by extraction with ethyl acetate
  6. customThe solvent was evaporated
  7. customthe residue was purified through silica gel column chromatography (n-hexane:ethyl acetate=1:1)

출처 및 근거

ORD 기록
ord-749391b8ee554b64a7a59308da093184
출처 데이터셋
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08022075B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트